Gastroenterology
Volume 129, Issue 2 , Pages 504-511 , August 2005

Probability of Pancreatic Cancer Following Diabetes: A Population-Based Study

  • Suresh T. Chari

      Affiliations

    • Division of Gastroenterology and Hepatology, Department of Internal Medicine, Rochester, Minnesota, USA
    • Corresponding Author InformationAddress requests for reprints to: Suresh T. Chari, MD, Mayo Clinic College of Medicine, Division of Gastroenterology and Hepatology, 200 First St SW, Rochester, Minnesota 55905. fax: (507) 284 5486.
    • ,
  • Cynthia L. Leibson

      Affiliations

    • Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota
    • ,
  • Kari G. Rabe

      Affiliations

    • Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota
    • ,
  • Jeanine Ransom

      Affiliations

    • Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota
    • ,
  • Mariza de Andrade

      Affiliations

    • Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota
    • ,
  • Gloria M. Petersen

      Affiliations

    • Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota

Received 17 January 2005 ,Accepted 20 April 2005.

References 

  1. Brentnall TA , Bronner MP , Byrd DR , Haggitt RC , Kimmey MB . Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer . Ann Intern Med . 1999;131:247–255
  2. Canto M, Wroblewski L, Goggins M, Petersen G, Brune K, Yea C, et al. Screening for pancreatic neoplasia in high-risk individuals (The Johns Hopkins Experience) . Gastroenterology . 2002;122(Suppl 1):A-17
  3. Goggins M , Canto M , Hruban R . Can we screen high-risk individuals to detect early pancreatic carcinoma? . J Surg Oncol . 2000;74:243–248
  4. Everhart J , Wright D . Diabetes mellitus as a risk factor for pancreatic cancer (a meta-analysis) . JAMA . 1995;273:1605–1609
  5. Ragozzino M , Melton LJD , Chu CP , Palumbo PJ . Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus . J Chronic Dis . 1982;35:13–19
  6. Wideroff L, Gridley G, Mellemkjaer L, Chow WH, Linet M, Keehn S, et al. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark . J Natl Cancer Inst . 1997;89:1360–1365
  7. Calle EE , Murphy TK , Rodriguez C , Thun MJ , Heath CW . Diabetes mellitus and pancreatic cancer mortality in a prospective cohort of United States adults . Cancer Causes Control . 1998;9:403–410
  8. Adami HO, McLaughlin J, Ekbom A, Berne C, Silverman D, Hacker D, et al. Cancer risk in patients with diabetes mellitus . Cancer Causes Control . 1991;2:307–314
  9. Chow WH, Gridley G, Nyren O, Linet MS, Ekbom A, Fraumeni JF, et al. Risk of pancreatic cancer following diabetes mellitus (a nationwide cohort study in Sweden) . J Natl Cancer Inst . 1995;87:930–931
  10. Cersosimo E , Pisters PW , Pesola G , McDermott K , Bajorunas D , et al.   Insulin secretion and action in patients with pancreatic cancer . Cancer . 1991;67:486–493
  11. Permert J , Ihse I , Jorfeldt L , von Schenck H , Arnqvist HJ , Larsson J . Pancreatic cancer is associated with impaired glucose metabolism . Eur J Surg . 1993;159:101–107
  12. Permert J , Larsson J , Ihse I , Pour PM . Diagnosis of pancreatic cancer. Alteration of glucose metabolism . Int J Pancreatol . 1991;9:113–117
  13. Chari ST , Klee GG , Miller LJ , Raimondo M , DiMagno EP . Islet amyloid polypeptide is not a satisfactory marker for detecting pancreatic cancer . Gastroenterology . 2001;121:640–645
  14. Silverman DT, Swanson CA, Gridley G, Wacholder S, Greenberg RS, Brown LM, et al. Dietary and nutritional factors and pancreatic cancer (a case control study based on direct interviews) . J Natl Cancer Inst . 1998;90:1710–1719
  15. Jain M , Howe GR , St Louis P , Miller AB . Coffee and alcohol as determinants of risk of pancreas cancer (a case control study from Toronto) . Int J Cancer . 1991;47:384–389
  16. Gullo L , Pezzilli R , Morselli-Labate AM  Italian Pancreatic Cancer Study Group . Diabetes and the risk of pancreatic cancer . N Engl J Med . 1994;331:81–84
  17. Moossa AR , Levin B . Collaborative studies in the diagnosis of pancreatic cancer . Semin Oncol . 1979;6:298–308
  18. Moossa AR , Levin B . The diagnosis of “early” pancreatic cancer (the University of Chicago experience) . Cancer . 1968;47:1688–1697
  19. Bonelli L, Aste H, Bovo P, Cavallini G, Felder M, Gusmaroli R, et al. Exocrine pancreatic cancer, cigarette smoking, and diabetes mellitus (a case-control study in northern Italy) . Pancreas . 2003;27:143–149
  20. Cuzick J , Babiker AG . Pancreatic cancer, alcohol, diabetes mellitus and gall-bladder disease . Int J Cancer . 1989;43:415–421
  21. Permert J , Ihse I , Jorfeldt L , von Schenck H , Arnquist HJ , Larsson J . Improved glucose metabolism after subtotal pancreatectomy for pancreatic cancer . Br J Surg . 1993;80:1047–1050
  22. Noy A , Bilezikian JP . Clinical review 63: diabetes and pancreatic cancer: clues to the early diagnosis of pancreatic malignancy . J Clin Endocrinol Metab . 1994;79:1223–1231
  23. Levine W , Dyer AR , Shekelle RB , Schoenberger JA , Stamler J . Post-load plasma glucose and cancer mortality in middle-aged men and women. 12-year follow-up findings of the Chicago Heart Association Detection Project in Industry . Am J Epidemiol . 1990;131:254–262
  24. Gapstur SM , Gann PH , Lowe W , Liu K , Colangelo L , Dyer A . Abnormal glucose metabolism and pancreatic cancer mortality . JAMA . 2000;283:2552–2558
  25. Smith GD , Egger M , Shipley MJ , Marmot MG . Post-challenge glucose concentration, impaired glucose tolerance, diabetes, and cancer mortality in men . Am J Epidemiol . 1992;136:1110–1114
  26. Melton LJ . History of the Rochester Epidemiology Project . Mayo Clin Proc . 1996;71:266–274
  27. Burke JP, O’Brien P, Ransom J, Palumbo PJ, Lydick E, Yawn BP, et al. Impact of case ascertainment on recent trends in diabetes incidence in Rochester, Minnesota . Am J Epidemiol . 2002;155:859–865
  28. Leibson CL, Williamson DF, Melton LJ, Palumbo PJ, Smith SA, Ransom JE, et al. Temporal trends in BMI among adults with diabetes . Diabetes Care . 2001;24:1584–1589
  29. Thomas RJ, Palumbo PJ, Melton LJ, Roger VL, Ransom J, O’Brien PC, et al. Trends in the mortality burden associated with diabetes mellitus (a population-based study in Rochester, Minn, 1970–1994) . Arch Intern Med . 2003;163:445–451
  30. National Diabetes Data Group . Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance . Diabetes Care . 1979;28:1039–1057
  31. West K . Standardization of definition, classification, and reporting in diabetes-related epidemiologic studies . Diabetes Care . 1979;2:65–76
  32. Melton LJ . The threat to medical-records research . N Engl J Med . 1997;337:1466–1470
  33. National Cancer Institute. Surveillance and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence-SEER 9 Regs Public-Use, Nov 2002 Sub (1973–2000) <18 Age Groups>, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2003, based on the November 2002 submission.
  34. Riela A , Zinsmeister AR , Melton LJ , Weiland LH , DiMagno EP . Increasing incidence of pancreatic cancer among women in Olmsted County, Minnesota, 1940 through 1988 . Mayo Clin Proc . 1992;67:839–845
  35. Bergstalh EJ, Offord KP, Kosanke JL, Augustine GA. PERSONYEARS: a SAS procedure for person year analyses: Rochester, MN: Section of Medical Research Statistics, Mayo Clinic; April 1986. Technical Report Series, No.31.
  36. Breslow NE , Day NE . Statistical methods in cancer research. IARC Workshop. IARC Scientific Publications. Volume No. 82 . Lyon, France: IARC; 1987;
  37. Burke JPWK , Gaskill SP , Hazuda HP , Haffner SM , Stern MP . Rapid rise in the incidence of type 2 diabetes from 1987 to 1996 (results from the San Antonio Heart Study) . Arch Intern Med . 1999;159:1450–1456
  38. Damiano J, Bordier L, Le Berre JP, Margery J, Dupuy O, Mayaudon H, et al. Should pancreas imaging be recommended in patients over 50 years when diabetes is discovered because of acute symptoms? . Diabetes Metab . 2004;30:203–207
  39. Ogawa Y, Tanaka M, Inoue K, Yamaguchi K, Chijiiwa K, Mizumoto K, et al. A prospective pancreatographic study of the prevalence of pancreatic carcinoma in patients with diabetes mellitus . Cancer . 2002;94:2344–2349
  40. Gangi S, Fletcher JG, Nathan MA, Christensen JA, Harmsen WS, Crownhart BS, et al. Time interval between abnormalities seen on CT and the clinical diagnosis of pancreatic cancer (retrospective review of CT scans obtained before diagnosis) . AJR Am J Roentgenol . 2004;182:897–903
  41. Tsuchiya R , Noda T , Harada N , Miyamoto T , Tomioka T , et al.   Collective review of small carcinomas of the pancreas . Ann Surg . 1986;203:77–81
  42. Ahren B , Andren-Sandberg A . Glucose tolerance and insulin secretion in experimental pancreatic cancer in the Syrian hamster . Res Exp Med . 1993;193:21–26
  43. Harris MI , Klein R , Welborn TA , Knuiman MW . Onset of NIDDM occurs at least 4–7 yr before clinical diagnosis . Diabetes Care . 1992;15:815–819
  44. Harris MIFK, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988–1994 . Diabetes Care . 1998;21:518–524
  45. Basso D, Valerio A, Seraglia R, Mazza S, Piva MG, Greco E, et al. Putative pancreatic cancer-associated diabetogenic factor (2030 MW peptide) . Pancreas . 2002;24:8–14
  46. Berrington de Gonzalez ASS , Spencer E . A meta-analysis of obesity and the risk of pancreatic cancer . Br J Cancer . 2003;89:519–523

 Supported by NIH grants R01 CA 100685 (to S.T.C.) and R01 CA 100685 and P20 CA 10270 (to G.M.P. and M.A.), the Lustgarten Foundation (to S.T.C.), and SmithKline Beecham Pharmaceuticals (to C.L.L.).The grants and sponsors did not influence design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.

PII: S0016-5085(05)00877-2

doi: 10.1053/j.gastro.2005.05.007

Gastroenterology
Volume 129, Issue 2 , Pages 504-511 , August 2005

Article Tools

* Image Usage & Resolution